Literature DB >> 3082544

Responsiveness to live M. tuberculosis, and common antigens, of sonicate-stimulated T cell lines from normal donors.

G A Rook, J Steele, S Barnass, J Mace, J L Stanford.   

Abstract

Live mycobacteria are more efficient vaccines against mycobacterial disease than killed ones. A possible explanation is the existence of important protective antigens released by live bacilli, which are not present in any significant quantity in dead ones. Conversely, internal mycobacterial antigens may be irrelevant to protection if not released by live bacilli. We show here, using T cell lines derived by limiting dilution from the peripheral blood of normal donors stimulated with sonicated BCG, that a variable percentage of sonicate responsive T cells is unable to respond to live M. tuberculosis. The possibility that such lines have an immunopathological, rather than protective role, is discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3082544      PMCID: PMC1577333     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  11 in total

1.  Vaccination against tuberculosis with nonliving vaccines. I. The problem and its historical background.

Authors:  D W WEISS
Journal:  Am Rev Respir Dis       Date:  1959-11

2.  B.C.G. vaccination of children against leprosy in Uganda: results at end of second follow-up.

Authors:  J A Brown; M M Stone; I Sutherland
Journal:  Br Med J       Date:  1968-01-06

3.  Skin-test sensitisation by tubercle bacilli and by other mycobacteria in Ethiopian school-children.

Authors:  E Lema; J Stanford
Journal:  Tubercle       Date:  1984-12

4.  The immunogenicity of killed mycobacteria.

Authors:  G A Rook
Journal:  Lepr Rev       Date:  1980-12       Impact factor: 0.537

5.  Long-term results of BCG vaccination in the southern United States.

Authors:  G W Comstock; C E Palmer
Journal:  Am Rev Respir Dis       Date:  1966-02

6.  Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumor T cells.

Authors:  H Rabin; R F Hopkins; F W Ruscetti; R H Neubauer; R L Brown; T G Kawakami
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

7.  Quantification of antigen-reactive cells among human T lymphocytes.

Authors:  M H van Oers; J Pinkster; W P Zeijlemaker
Journal:  Eur J Immunol       Date:  1978-07       Impact factor: 5.532

8.  Antigen-specific human T-lymphocyte clones. Genetic restriction of influenza virus-specific responses to HLA-D region genes.

Authors:  D D Eckels; J R Lamb; P Lake; J N Woody; A H Johnson; R J Hartzman
Journal:  Hum Immunol       Date:  1982-07       Impact factor: 2.850

9.  Infection with Mycobacterium avium-intracellulare and the protective effects of Bacille Calmette-Guérin.

Authors:  M L Edwards; J M Goodrich; D Muller; A Pollack; J E Ziegler; D W Smith
Journal:  J Infect Dis       Date:  1982-05       Impact factor: 5.226

10.  I-A restricted activation by T cell lines of anti-tuberculosis activity in murine macrophages.

Authors:  G A Rook; B R Champion; J Steele; A M Varey; J L Stanford
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

View more
  13 in total

1.  T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis.

Authors:  P Andersen; D Askgaard; L Ljungqvist; M W Bentzon; I Heron
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

Review 2.  Immunological study of the defined constituents of mycobacteria.

Authors:  J Ivanyi; K Sharp; P Jackett; G Bothamley
Journal:  Springer Semin Immunopathol       Date:  1988

Review 3.  Progress in the immunology of the mycobacterioses.

Authors:  G A Rook
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

4.  Differential immunogenicity of novel Mycobacterium tuberculosis antigens derived from live and dead bacilli.

Authors:  R R Amara; V Satchidanandam
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

5.  Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis.

Authors:  A D Roberts; M G Sonnenberg; D J Ordway; S K Furney; P J Brennan; J T Belisle; I M Orme
Journal:  Immunology       Date:  1995-07       Impact factor: 7.397

6.  The Mycobacterium leprae antigen 85 complex gene family: identification of the genes for the 85A, 85C, and related MPT51 proteins.

Authors:  T F Rinke de Wit; S Bekelie; A Osland; B Wieles; A A Janson; J E Thole
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

7.  Dendritic cells efficiently immunoselect mycobacterial-reactive T cells in human blood, including clonable antigen-reactive precursors.

Authors:  P Pancholi; R M Steinman; N Bhardwaj
Journal:  Immunology       Date:  1992-06       Impact factor: 7.397

8.  Characterization of fibronectin-binding antigens released by Mycobacterium tuberculosis and Mycobacterium bovis BCG.

Authors:  C Abou-Zeid; T L Ratliff; H G Wiker; M Harboe; J Bennedsen; G A Rook
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

Review 9.  Early T-cell responses in tuberculosis immunity.

Authors:  Gary M Winslow; Andrea Cooper; William Reiley; Madhumouli Chatterjee; David L Woodland
Journal:  Immunol Rev       Date:  2008-10       Impact factor: 12.988

Review 10.  The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis.

Authors:  H G Wiker; M Harboe
Journal:  Microbiol Rev       Date:  1992-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.